Risk-adapted letermovir prophylaxis based on a scoring system predicting a higher burden of cytomegalovirus exposure after allogeneic hematopoietic cell transplantation.
Kawamura S, Fujiwara SI, Kimura SI, Takeshita J, Nakasone H, Yoshimura K, Nakata Y, Ishikawa T, Matsuoka A, Meno T, Nakamura Y, Kawamura M, Yoshino N, Misaki Y, Gomyo A, Kusuda M, Murahashi R, Umino K, Minakata D, Ashizawa M, Yamamoto C, Hatano K, Sato K, Ohmine K, Kako S, Kanda Y.
Kawamura S, et al.
Transplant Cell Ther. 2025 Jan 17:S2666-6367(25)00911-X. doi: 10.1016/j.jtct.2025.01.883. Online ahead of print.
Transplant Cell Ther. 2025.
PMID: 39828058